SOLNA, STOCKHOLM REGION, SWEDEN – December 15, 2025 – Barnik Invest announces an initial investment in MedStorm Innovation AS. MedStorm Innovation is a medical technology company specializing in the objective, real-time assessment of pain and nociception across all age groups. MedStorm’s core technology measures skin sympathetic nerve activity via skin conductance, reflecting

SOLNA, STOCKHOLM REGION, SWEDEN – October 7, 2025 – Barnik Invest is proud to announce the official incorporation of its portfolio company, Bonipharmex AB. The establishment of the company is the result of a successful joint venture between StartUpPharma Sweden and DynalisPharma Switzerland, aimed at developing and commercializing a novel concept of

SOLNA, STOCKHOLM REGION, SWEDEN – August 26, 2025 – Barnik Invest, a leading360 solution investment partner for Life Science companies, today announced itsparticipation in the Advanced Therapies Europe 2025 conference. The exclusive event,taking place from September 2-4 in Barcelona, will bring together 500 of the mostinfluential minds in cell and gene therapy,

Solna, Stockholm, Sweden – March 12, 2025 – Barnik Invest’s Portfolio Company, Cell4Cure AB, a pioneering Swedish biotech company developing innovative immune tolerance therapies, last week announced its strategic partnership with Bartlett Hill Partners LLC, a leading advanced therapies consulting group based in Boston, to spearhead its North American business development initiatives.

Stockholm, Sweden – Barnik Invest Group today announced the bolagization of its joint venture project with DynalisPharma, resulting in the formation of BoniPharmex AB. This strategic move solidifies the partnership and positions BoniPharmex for significant growth in the market for probiotics and dietary supplements BoniPharmex was initially founded in 2021 as a

Stockholm, Sweden – Barnik Invest Group, an investment firm dedicated to pioneering the advancement of innovative life science companies in the Nordics, today announced the formation of Barnik Holdings AB. This new holding company will serve as the umbrella entity for all Barnik Invest Group portfolio companies. Barnik Holdings AB will offer

Stockholm, Sweden – Barnik Invest Group, today announced the appointment of Dr. Benedict Broennimann as Chief Scientific Officer. Dr. Broennimann is a highly accomplished medical and business executive with over 20 years of experience in the Life sciences industry. His extensive expertise and leadership will be invaluable as Barnik Invest Group continues

Stockholm, Sweden – Barnik Invest Group, today announced its participation in the 50th edition of Arab Health, taking place at the Dubai World Trade Centre from January 27-30, 2025. Barnik Invest Group will showcase its diverse portfolio of innovative companies at the event. Visitors to the Barnik Invest Group booth will have